Affiliation:
1. Bengaluru Neuro Centre, Bengaluru, Karnataka 560003, India
2. Inventia Healthcare Ltd., Mumbai, Maharashtra 400069, India
3. Laila Nutraceuticals, Vijayawada, Andhra Pradesh 520007, India
4. Sumana Vinayaka Nursing Home, Mandya, Karnataka 571401, India
5. In Vitro Research Solutions (iVRS) Pvt Ltd., Bengaluru, Karnataka 560092, India
Abstract
Background. The global prevalence of stress is increasing. Stress adversely affects cognitive ability, sleep quality, and overall psychological well-being. Ashwagandha (Withania somnifera (L.) Dunal), an essential medicine in Ayurveda, is reportedly beneficial in reducing stress and improving memory. This double-blind, randomized, placebo-controlled clinical study evaluated the effect of Ashwagandha root extract sustained-release capsule 300 mg (Prolanza™; hereafter Ashwagandha SR) on cognitive functions, stress levels, sleep quality, overall well-being, and safety in stressed subjects. Methods. Subjects (130 healthy cognitively sound adults [20–55 years, body mass index:18–29 kg/m2]) having a Perceived Stress Scale (PSS) score of 14–24 were randomized to receive either Ashwagandha SR or placebo. Subjects took one capsule of Ashwagandha SR or placebo daily for 90 consecutive days. This study was registered on Clinical Trials Registry-India (CTRI) on 13/11/2019 [number: CTRI/2019/11/021990]. The primary endpoint was the change in cognitive function as measured by CANTAB from baseline to the end of the study period (90 ± 7 days). The secondary outcomes included the change in PSS-10 score, serum cortisol level (9–11 am), the OHQ score, the PSQI, and serum BDNF levels. Results. Only 125 completed the study and were evaluated. The Cambridge Neuropsychological Test Automated Battery (CANTAB) reported significantly improved recall memory, and the total error rate in recalling patterns significantly decreased at visit 4 in the Ashwagandha SR group vs. the placebo group (first attempt memory score:12.9 ± 6.7 vs. 10.1 ± 6.3; total errors:17.5 ± 23.3 vs. 27.7 ± 23.6). At visit 4, lower PSS-10 score (13.0 ± 5.0 vs. 18.7 ± 4.6;
), serum cortisol levels
, and Pittsburgh Sleep Quality Index (PSQI) score
but higher Oxford Happiness Questionnaire (OHQ) scores
were seen in Ashwagandha SR vs. the placebo group, suggesting significantly lower stress levels and significantly better psychological well-being and sleep quality in the former. No adverse events were reported. Conclusions. This is the first clinical study assessing Ashwagandha SR for its safety and efficacy. Treatment with one Ashwagandha SR capsule once daily for 90 days improved memory and focus, psychological well-being, and sleep quality, reduced stress levels, and was safe and well-tolerated.
Subject
Complementary and alternative medicine
Reference34 articles.
1. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis;S. Nader;Globalization and Health,2020
2. Stress and cognition;W. Jianhui;Frontiers in Psychology,2017
3. Stress and cognition in humans;D. Gregor;Journal of Experimental Psychology,2020
4. The influence of sleep on human hypothalamic–pituitary–adrenal (HPA) axis reactivity: A systematic review
5. The role of sleep quality, trait anxiety and hypothalamic-pituitary-adrenal axis measures in cognitive abilities of healthy individuals;J. Labad;International Journal of Environmental Research and Public Health,2020
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献